Impact of diabetes mellitus on long-term prognosis after gastrectomy for advanced gastric cancer: a propensity score matching analysis

被引:2
作者
Matsui, Ryota [1 ,2 ]
Inaki, Noriyuki [1 ,3 ]
Tsuji, Toshikatsu [1 ]
机构
[1] Ishikawa Prefectural Cent Hosp, Dept Gastroenterol Surg, Kanazawa, Ishikawa, Japan
[2] Juntendo Univ, Dept Surg, Urayasu Hosp, Urayasu, Japan
[3] Kanazawa Univ, Grad Sch Med Sci, Dept Gastrointestinal Surg Breast Surg, 13-1 Takara Machi, Kanazawa, Ishikawa 9208641, Japan
关键词
Diabetes mellitus; Gastric cancer; Overall survival; Prognosis; Skeletal muscle mass; POSTOPERATIVE WEIGHT-LOSS; RISK-FACTOR; METAANALYSIS; OBESITY; DISEASE; CHEMOTHERAPY; SURVIVAL; PARADOX;
D O I
10.1007/s00595-022-02482-y
中图分类号
R61 [外科手术学];
学科分类号
摘要
Purpose We investigated the long-term prognostic impact of diabetes mellitus (DM) after gastrectomy for advanced gastric cancer. Methods This was a retrospective cohort study of consecutive patients who underwent gastrectomy for primary p-T2 or more advanced-stage gastric cancer, between April, 2008 and June, 2018. The overall survival (OS) of patients with DM and those without DM were compared using Kaplan-Meier survival analysis after adjusting for group differences using propensity score matching (PSM). Results Among the 512 patients who met the eligibility criteria, 92 (18.0%) had DM and 420 (82.0%) did not. After PSM, the subjects of this analysis were 72 patients in the DM group and 216 patients in the non-DM. OS was significantly worse in the DM group than in the non-DM group (P = 0.037). Multivariate analysis revealed that a low skeletal muscle mass index was a significant independent prognostic factor for OS in the patients with DM (hazard ratio, 2.284; 95% confidence interval, 1.005-5.189; P = 0.048). Conclusions DM in patients with advanced gastric cancer is associated with poor OS. A low skeletal muscle mass in patients with DM is a particularly poor prognostic factor for OS after surgery for gastric cancer.
引用
收藏
页码:1382 / 1391
页数:10
相关论文
共 29 条
[1]   Postoperative weight loss leads to poor survival through poor S-1 efficacy in patients with stage II/III gastric cancer [J].
Aoyama, Toru ;
Sato, Tsutomu ;
Maezawa, Yukio ;
Kano, Kazuki ;
Hayashi, Tsutomu ;
Yamada, Takanobu ;
Yukawa, Norio ;
Oshima, Takashi ;
Rino, Yasushi ;
Masuda, Munetaka ;
Ogata, Takashi ;
Cho, Haruhiko ;
Yoshikawa, Takaki .
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2017, 22 (03) :476-483
[2]   Body Weight Loss After Surgery is an Independent Risk Factor for Continuation of S-1 Adjuvant Chemotherapy for Gastric Cancer [J].
Aoyama, Toru ;
Yoshikawa, Takaki ;
Shirai, Junya ;
Hayashi, Tsutomu ;
Yamada, Takanobu ;
Tsuchida, Kazuhito ;
Hasegawa, Shinichi ;
Cho, Haruhiko ;
Yukawa, Norio ;
Oshima, Takashi ;
Rino, Yasushi ;
Masuda, Munetaka ;
Tsuburaya, Akira .
ANNALS OF SURGICAL ONCOLOGY, 2013, 20 (06) :2000-2006
[3]   The obesity paradox: Impact of obesity on the prevalence and prognosis of cardiovascular diseases [J].
Artham, Surya M. ;
Lavie, Carl J. ;
Milani, Richard V. ;
Ventura, Hector O. .
POSTGRADUATE MEDICINE, 2008, 120 (02) :34-41
[4]  
Bang YJ, 2010, LANCET, V376, P1302
[5]   Oral Drugs Related with Muscle Wasting and Sarcopenia. A Review [J].
Campins, Lluis ;
Camps, Marcella ;
Riera, Ariadna ;
Pleguezuelos, Eulogio ;
Carlos Yebenes, Juan ;
Serra-Prat, Mateu .
PHARMACOLOGY, 2017, 99 (1-2) :1-8
[6]   Impact of diabetes on prognosis of gastric cancer patients performed with gastrectomy [J].
Chen, Xinhua ;
Chen, Yuehong ;
Li, Tao ;
Jun, Luo ;
Lin, Tian ;
Hu, Yanfeng ;
Huang, Huilin ;
Chen, Hao ;
Liu, Hao ;
Li, Tuanjie ;
Li, Guoxin ;
Yu, Jiang .
CHINESE JOURNAL OF CANCER RESEARCH, 2020, 32 (05) :631-+
[7]   Metformin Use and Gastric Cancer Risk in Diabetic Patients After Helicobacter pylori Eradication [J].
Cheung, Ka Shing ;
Chan, Esther W. ;
Wong, Angel Y. S. ;
Chen, Lijia ;
Seto, Wai Kay ;
Wong, Ian C. K. ;
Leung, Wai K. .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2019, 111 (05) :484-489
[8]   Obesity and Cancer: Evidence, Impact, and Future Directions [J].
Colditz, Graham A. ;
Peterson, Lindsay L. .
CLINICAL CHEMISTRY, 2018, 64 (01) :154-162
[9]  
Emerging Risk Factors Collaboration, 2010, Lancet, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9
[10]   Diabetes mellitus and risk of gastric cancer: a systematic review and meta-analysis of observational studies [J].
Ge, Zhenming ;
Ben, Qiwen ;
Qian, Junbo ;
Wang, Yamin ;
Li, Yuming .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2011, 23 (12) :1127-1135